Offer - Urjas Oil for just ₹ 1
Lenmid 5 Capsule is a commercial drug that is prescribed in the form of Capsule. Multiple Myeloma are some of its major therapeutic uses. Lenmid 5 Capsule also has some secondary and off-label uses. These are listed below.
The correct dosage of Lenmid 5 Capsule depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Lenmid 5 Capsule are Weakness, Sleepiness, Edema. While these are the most often observed Lenmid 5 Capsule side effects, there are can be others also. These have been listed below. Usually, these side effects of Lenmid 5 Capsule go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Lenmid 5 Capsule's effect during pregnancy is Severe and Severe while nursing. In addition, Lenmid 5 Capsule's effects on the liver, heart and kidney are discussed below in the Lenmid 5 Capsule related warnings section.
Lenmid 5 Capsule is not recommended if you suffer from certain medical conditions as it can have adverse effects. Neutropenia are examples of such conditions. Other conditions have been mentioned below in the Lenmid 5 Capsule contraindications section.
Drug interactions for Lenmid 5 Capsule have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Lenmid 5 Capsule is considered not safe while driving, and is not addictive.
Lenmid 5 Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Lenmid 5 Capsule safe for pregnant women?
Lenmid can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Lenmid 5 Capsule safe during breastfeeding?
Lenmid may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Lenmid 5 Capsule on the Kidneys?
There may be some adverse effects on kidney after taking Lenmid. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Lenmid 5 Capsule on the Liver?
Lenmid can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Lenmid 5 Capsule on the Heart?
There may be an adverse effect on the heart after taking Lenmid. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Lenmid 5 Capsule unless your doctor advises you to do so -
Is this Lenmid 5 Capsule habit forming or addictive?
No, you will not get addicted to Lenmid 5 Capsule.
Is it safe to drive or operate heavy machinery when consuming?
After taking Lenmid 5 Capsule you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Lenmid 5 Capsule only as per medical advice.
Is it able to treat mental disorders?
No, Lenmid 5 Capsule is not used to treat mental disorders.
Interaction between Food and Lenmid 5 Capsule
Taking Lenmid 5 Capsule with food does not harm your health.
Interaction between Alcohol and Lenmid 5 Capsule
No research has been done on this till date. Therefore, it is not known what the effect of taking Lenmid 5 Capsule with alcohol will be.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 753-755
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Revlimid (lenalidomide)
